InterCure to Hold 2021 Q4 & Year-End Webcast
March 30, 2022 09:00 ET
|
InterCure Ltd.
NEW YORK, TORONTO, and HERZLIYA, Israel, March 30, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that...
InterCure and Clever Leaves Announce International Strategic Partnership
March 22, 2022 08:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO, and HERZLIYA, Israel, March 22, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) and Clever Leaves...
InterCure to Participate in ROTH Capital’s 34th Annual Conference
March 15, 2022 11:34 ET
|
InterCure Ltd.
NEW YORK, TORONTO, and HERZLIYA, Israel, March 15, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that...
InterCure Announces Partnership with Altman Health
March 01, 2022 01:00 ET
|
InterCure Ltd.
The partnership will focus on the new CBD wellness market in Israel Israeli Minister of Health announced yesterday that CBD will be removed from the Dangerous Drugs Act Altman Health...
InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer “Better”
February 16, 2022 01:00 ET
|
InterCure Ltd.
Marking the First Major Consolidation in Pharmaceutical Grade Medical Cannabis Market Acquisition is Expected to be Accretive Strengthen InterCure’s Position as the Largest Cannabis Company Outside...
InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue - 3 Times YoY and 24% QoQ Growth
February 08, 2022 01:00 ET
|
InterCure Ltd.
Estimated revenue reaches over CAD$31 million (a record NIS 77 million) Anticipates continued increases in adjusted operating profit and EBITDA Revenue growth expected to continue...
InterCure Announces European Expansion with International Cannabis Brand Cookies
December 02, 2021 08:15 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 02, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced its...
InterCure to Participate in Cowen’s 4th Annual Cannabis Conference
November 29, 2021 08:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 29, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced...
InterCure Announces Record Third Quarter Financial Results with 3 Times YoY Revenue Growth and 36% QoQ Growth
November 15, 2021 19:00 ET
|
InterCure Ltd.
Seventh consecutive quarter of high double-digit, sequential revenue growth Annualized revenues run rate of $100 million Adjusted EBITDA1 run rate of $23 million $85 million in cash ...
InterCure Expands Pharmacy Chain in Israel; Surpasses One-Ton Medical Cannabis Products Dispensed Per Month
November 15, 2021 18:50 ET
|
InterCure Ltd.
With addition of four new pharmacies, InterCure’s dedicated chain GIVOL now has 20 locations across Israel NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- InterCure...